Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 10

1.

Anticancer agent pristimerin inhibits IL-2 induced activation of T lymphocytes.

Liu Y, Gao X, Deeb D, Zhang Y, Shaw J, Gautam SC.

J Exp Ther Oncol. 2016 Jul;11(3):181-188.

PMID:
28471123
2.

Interleukin-2 and Interleukin-8 Gene Polymorphisms and Acquired Aplastic Anemia Risk in a Chinese Population.

Zhang X, Lin S, Yang Y, Rong L, He G, He H, Xue Y, Fang Y, Wang Y.

Cell Physiol Biochem. 2017;41(3):1199-1207. doi: 10.1159/000464381. Epub 2017 Mar 6.

3.

Adoptive immunotherapy with interleukin-2 & induced killer cells in non-small cell lung cancer: A systematic review & meta-analysis.

Mi D, Ren W, Yang K.

Indian J Med Res. 2016 May;143(Supplement):S1-S10. doi: 10.4103/0971-5916.191738. Review.

4.

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma.

Takezawa Y, Izumi K, Shimura Y, Aerken M, Natsagdorji A, Iijima M, Shigehara K, Nohara T, Narimoto K, Kadono Y, Kitagawa Y, Konaka H, Mizokami A.

Anticancer Res. 2016 Sep;36(9):4961-4.

PMID:
27630356
5.

Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection.

Dagenais-Lussier X, Aounallah M, Mehraj V, El-Far M, Tremblay C, Sekaly RP, Routy JP, van Grevenynghe J.

J Virol. 2016 Aug 12;90(17):7967-79. doi: 10.1128/JVI.00994-16. Print 2016 Sep 1.

6.

Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

Schorle H, Holtschke T, H√ľnig T, Schimpl A, Horak I.

Nature. 1991 Aug 15;352(6336):621-4.

PMID:
1830926
7.

Unraveling the structure of IL-2.

Bazan JF.

Science. 1992 Jul 17;257(5068):410-3. No abstract available.

PMID:
1631562
8.

Secondary structure of human interleukin 2 from 3D heteronuclear NMR experiments.

Mott HR, Driscoll PC, Boyd J, Cooke RM, Weir MP, Campbell ID.

Biochemistry. 1992 Aug 25;31(33):7741-4.

PMID:
1510960
9.
10.

Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2.

Brodie C, Gelfand EW.

J Immunol. 1992 Jun 1;148(11):3492-7.

PMID:
1316918

Supplemental Content

Support Center